 |
Combretastatin A4 phosphate |
|---|---|
| Trade Name | |
| Orphan Indication | Ovarian cancer |
| USA Market Approval | USA |
| USA Designation Date | 2006-05-08 00:00:00 |
| Sponsor | Mateon Therapeutics, Inc.;701 Gateway Blvd, Suite 210;South San Francisco, California, 94080 |
| |
Combretastatin A4 phosphate |
|---|---|
| Trade Name | |
| Orphan Indication | Ovarian cancer |
| USA Market Approval | USA |
| USA Designation Date | 2006-05-08 00:00:00 |
| Sponsor | Mateon Therapeutics, Inc.;701 Gateway Blvd, Suite 210;South San Francisco, California, 94080 |